Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in CorMedix Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
129
+29 vs. Q3 2024
Shares held
23.0M
+3.94M (+20.7%) vs. Q3 2024
Total value
$186.1M
+$32.4M (+21.1%) vs. Q3 2024
New holders
40
50 more added
Sold out
11
23 more reduced

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 129 institutions
Q1 2021: 79 institutionsQ2 2021: 79 institutionsQ3 2021: 79 institutionsQ4 2021: 80 institutionsQ1 2022: 85 institutionsQ2 2022: 74 institutionsQ3 2022: 73 institutionsQ4 2022: 66 institutionsQ1 2023: 66 institutionsQ2 2023: 86 institutionsQ3 2023: 92 institutionsQ4 2023: 101 institutionsQ1 2024: 90 institutionsQ2 2024: 99 institutionsQ3 2024: 102 institutionsQ4 2024: 129 institutionsQ1 2025: 136 institutionsQ2 2025: 172 institutionsQ3 2025: 190 institutionsQ4 2025: 200 institutionsQ1 2026: 188 institutionsQ2 2026: 193 institutions
Value heldQ4 2024: $186.1M
Q1 2021: $107.6MQ2 2021: $78.0MQ3 2021: $55.0MQ4 2021: $59.4MQ1 2022: $73.4MQ2 2022: $49.4MQ3 2022: $31.3MQ4 2022: $47.1MQ1 2023: $44.7MQ2 2023: $76.1MQ3 2023: $66.2MQ4 2023: $70.5MQ1 2024: $73.2MQ2 2024: $74.3MQ3 2024: $154.7MQ4 2024: $186.1MQ1 2025: $144.9MQ2 2025: $420.8MQ3 2025: $501.5MQ4 2025: $488.3MQ1 2026: $279.8MQ2 2026: $345.5M
Institutions holding CRMD and their total value by quarter
QuarterHoldersValue
Q2 2026193$345.5M
Q1 2026188$279.8M
Q4 2025200$488.3M
Q3 2025190$501.5M
Q2 2025172$420.8M
Q1 2025136$144.9M
Q4 2024129$186.1M
Q3 2024102$154.7M
Q2 202499$74.3M
Q1 202490$73.2M
Q4 2023101$70.5M
Q3 202392$66.2M
Q2 202386$76.1M
Q1 202366$44.7M
Q4 202266$47.1M
Q3 202273$31.3M
Q2 202274$49.4M
Q1 202285$73.4M
Q4 202180$59.4M
Q3 202179$55.0M
Q2 202179$78.0M
Q1 202179$107.6M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding CorMedix Inc.; share changes are against Q3 2024.

Institutions holding CRMD in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Raymond James Financial Inc115,661$936.9K0.00%+115,661New
Wingate Wealth Advisors, Inc.126,015$1.02M1.00%+126,015New
Bank of New York Mellon Corp129,695$1.05M0.00%+9,782+8.2%Added
Renaissance Technologies LLC134,000$1.09M0.00%+134,000New
Steward Partners Investment Advisory, LLC149,834$1.21M0.01%+3,221+2.2%Added
New York State Common Retirement Fund167,249$1.35M0.00%+156,086+1,398.2%Added
Nuveen Asset Management, LLC171,978$1.39M0.00%+1,679+1.0%Added
Charles Schwab Investment Management Inc174,418$1.41M0.00%+17,869+11.4%Added
Spinnaker Capital LLC175,384$1.42M100.00%00.0%Unchanged
Millennium Management LLC178,134$1.44M0.00%+87,896+97.4%Added
Wellington Management Group LLP178,786$1.45M0.00%−2,162−1.2%Reduced
Goldman Sachs Group Inc198,920$1.61M0.00%+63,532+46.9%Added
Simplex Trading, LLC210,356$1.70M0.05%−10,961−5.0%Reduced
JPMorgan Chase & Co273,218$2.21M0.00%+79,110+40.8%Added
Citadel Advisors LLC293,637$2.38M0.00%+167,041+131.9%Added
Group One Trading, L.P.312,081$2.53M0.09%−9,700−3.0%Reduced
Palisades Investment Partners, LLC364,019$2.95M1.24%+364,019New
Kennedy Capital Management, Inc.378,243$3.06M0.07%−1,701−0.4%Reduced
UBS Group AG379,868$3.08M0.00%+340,352+861.3%Added
Morgan Stanley398,849$3.23M0.00%+56,463+16.5%Added
D. E. Shaw & Co., Inc.446,414$3.62M0.00%+125,425+39.1%Added
J. Goldman & Co LP457,320$3.70M0.13%+314,880+221.1%Added
Northern Trust Corp511,565$4.14M0.00%+64,243+14.4%Added
First Turn Management, LLC1,021,421$8.27M1.48%+1,021,421New
Geode Capital Management, LLC1,392,820$11.3M0.00%+108,356+8.4%Added
State Street Corp1,453,148$11.8M0.00%+227,392+18.6%Added
Elliott Investment Management L.P.SuperinvestorElliott Investment Management2,870,632$23.3M0.25%+1,320,109+85.1%Added
Vanguard Group Inc3,378,191$27.4M0.00%+309,514+10.1%Added
BlackRock, Inc.4,567,897$37.0M0.00%+911,603+24.9%Added
Rosalind Advisors, Inc.0$00.00%−1,475,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−161,755−100.0%Sold out
EAM Investors, LLC0$00.00%−130,036−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−125,700−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−11,825−100.0%Sold out
Pinnacle Associates Ltd0$00.00%−10,000−100.0%Sold out
Signaturefd, LLC0$00.00%−1,000−100.0%Sold out
Quantbot Technologies LP0$00.00%−628−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−47−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−31−100.0%Sold out
National Bank of Canada0$00.00%−2−100.0%Sold out
Raymond James Financial Services Advisors, Inc.––––Not filed
Raymond James & Associates––––Not filed